Director & President and COO
Director & President and COO at Bicara Therapeutics Inc., filing insider transactions between 2025-10-06 and 2026-05-15.
| SEC ↗ |
| 2026-04-15 | BCAX | Sale | 8,000 | $23.01 | $184K | SEC ↗ |
| 2026-03-16 | BCAX | Sale | 4,500 | $19.66 | $88K | SEC ↗ |
| 2026-03-16 | BCAX | Sale | 8,000 | $19.66 | $157K | SEC ↗ |
| 2026-03-03 | BCAX | Sale | 12.9K | $18.16 | $234K | SEC ↗ |
| 2026-03-03 | BCAX | Sale | 4,500 | $18.16 | $82K | SEC ↗ |
| 2026-02-25 | BCAX | Sale | 3,108 | $18.04 | $56K | SEC ↗ |
| 2026-02-25 | BCAX | Sale | 523 | $18.04 | $9K | SEC ↗ |
| 2026-01-22 | BCAX | Sale | 3,828 | $18.10 | $69K | SEC ↗ |
| 2026-01-15 | BCAX | Sale | 149 | $18.02 | $3K | SEC ↗ |
| 2025-12-15 | BCAX | Sale | 8,000 | $18.68 | $149K | SEC ↗ |
| 2025-12-15 | BCAX | Sale | 4,500 | $18.68 | $84K | SEC ↗ |
| 2025-11-21 | BCAX | Sale | 4,500 | $18.05 | $81K | SEC ↗ |
| 2025-11-21 | BCAX | Sale | 8,000 | $18.05 | $144K | SEC ↗ |
| 2025-10-15 | BCAX | Sale | 8,000 | $18.16 | $145K | SEC ↗ |
| 2025-10-15 | BCAX | Sale | 4,500 | $18.16 | $82K | SEC ↗ |
| 2025-10-07 | BCAX | Sale | 8,000 | $18.06 | $144K | SEC ↗ |
| 2025-10-07 | BCAX | Sale | 2,900 | $18.06 | $52K | SEC ↗ |
| 2025-10-06 | BCAX | Sale | 15.6K | $18.06 | $282K | SEC ↗ |
| 2025-10-06 | BCAX | Sale | 24.0K | $18.06 | $433K | SEC ↗ |